Financial News
Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely"
February 09, 2023 at 05:24 AM EST
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ: TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely."
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
More News
View More
Tesla’s Robotaxi Goes Unsupervised: Is the Rally Justified? ↗
January 22, 2026
UAL Stock Taking Flight After Earnings Confirm Strong Demand ↗
January 22, 2026
Why Apple’s Sell-Off May Be Overdone Right Before Earnings ↗
January 22, 2026
Qualcomm Gets Crushed: $150 Is the Level to Watch Going Forward ↗
January 22, 2026
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
